28078640|t|Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods
28078640|a|Health-related quality of life (HRQOL) is arguably one of the most important measures in evaluating effectiveness of clinical treatments. At present, there is no disease - specific outcome measure to assess the HRQOL of children, adolescents and young adults with Neurofibromatosis Type 1 (NF1). This study aimed to develop the items and support the content validity for the Pediatric Quality of Life Inventory™ (PedsQL™) NF1 Module for children, adolescents and young adults. The iterative process included multiphase qualitative methods including a literature review, survey of expert opinions, semi-structured interviews, cognitive interviews and pilot testing. Fifteen domains were derived from the qualitative methods, with content saturation achieved, resulting in 115 items. The domains include skin, pain, pain impact, pain management, cognitive functioning, speech, fine motor, balance, vision, perceived physical appearance, communication, worry, treatment, medicines and gastrointestinal symptoms. This study is limited because all participants are recruited from a single - site. Qualitative methods support the content validity for the PedsQL™ NF1 Module for children, adolescents and young adults. The PedsQL™ NF1 Module is now undergoing national multisite field testing for the psychometric validation of the instrument development.
28078640	19	54	pediatric quality of life inventory	T170	UMLS:C2698752
28078640	55	79	neurofibromatosis type 1	T038	UMLS:C0027831
28078640	80	86	module	T170	UMLS:C3542953
28078640	246	256	evaluating	T058	UMLS:C0220825
28078640	274	293	clinical treatments	T058	UMLS:C1516635
28078640	319	326	disease	T038	UMLS:C0012634
28078640	421	445	Neurofibromatosis Type 1	T038	UMLS:C0027831
28078640	447	450	NF1	T038	UMLS:C0027831
28078640	458	463	study	T062	UMLS:C2603343
28078640	532	568	Pediatric Quality of Life Inventory™	T170	UMLS:C2698752
28078640	570	577	PedsQL™	T170	UMLS:C2698752
28078640	579	582	NF1	T038	UMLS:C0027831
28078640	583	589	Module	T170	UMLS:C3542953
28078640	638	647	iterative	T033	UMLS:C1854293
28078640	708	725	literature review	T170	UMLS:C0282441
28078640	727	733	survey	T170	UMLS:C0038951
28078640	807	820	pilot testing	T062	UMLS:C0031928
28078640	959	963	skin	T022	UMLS:C1123023
28078640	965	969	pain	T033	UMLS:C0030193
28078640	971	975	pain	T033	UMLS:C0030193
28078640	984	999	pain management	T058	UMLS:C0002766
28078640	1001	1022	cognitive functioning	T038	UMLS:C0392335
28078640	1024	1030	speech	T038	UMLS:C0037817
28078640	1053	1059	vision	T038	UMLS:C0042789
28078640	1061	1070	perceived	T038	UMLS:C0030971
28078640	1071	1090	physical appearance	T033	UMLS:C0750731
28078640	1107	1112	worry	T033	UMLS:C0233481
28078640	1114	1123	treatment	T058	UMLS:C0087111
28078640	1125	1134	medicines	T103	UMLS:C0013227
28078640	1139	1164	gastrointestinal symptoms	T033	UMLS:C0426576
28078640	1200	1212	participants	T098	UMLS:C0679646
28078640	1243	1247	site	T082	UMLS:C0205145
28078640	1306	1313	PedsQL™	T170	UMLS:C2698752
28078640	1314	1317	NF1	T038	UMLS:C0027831
28078640	1318	1324	Module	T170	UMLS:C3542953
28078640	1373	1380	PedsQL™	T170	UMLS:C2698752
28078640	1381	1384	NF1	T038	UMLS:C0027831
28078640	1385	1391	Module	T170	UMLS:C3542953
28078640	1451	1463	psychometric	T058	UMLS:C0033920
28078640	1464	1474	validation	T062	UMLS:C1519941
28078640	1482	1492	instrument	T170	UMLS:C0038951